TY - JOUR
T1 - Oral Appliance Treatment Response and Polysomnographic Phenotypes of Obstructive Sleep Apnea
AU - Sutherland, Kate
AU - Takaya, Hisashi
AU - Qian, Jin
AU - Petocz, Peter
AU - Ng, Andrew T.
AU - Cistulli, Peter A.
PY - 2015/8/15
Y1 - 2015/8/15
N2 - Study Objectives: Mandibular advancement splints (MAS) are an effective treatment for obstructive sleep apnea (OSA); however, therapeutic response is variable. Younger age, female gender, less obesity, and milder and supine-dependent OSA have variably been associated with treatment success in relatively small samples. Our objective was to utilize a large cohort of MAS treated patients (1) to compare effi cacy across patients with different phenotypes of OSA and (2) to assess demographic, anthropometric, and polysomnography variables as treatment response predictors. Methods: Retrospective analysis of MAS-treated patients participating in clinical trials in sleep centers in Sydney, Australia between years 2000-2013. All studies used equivalent customized two-piece MAS devices and treatment protocols. Treatment response was defi ned as (1) apneahypopnea index (AHI) < 5/h, (2) AHI < 10/h and ≥50% reduction, and (3) ≥ 50% AHI reduction. Results: A total of 425 patients (109 female) were included (age 51.2 ± 10.9 years, BMI 29.2 ± 5.0 kg/m2). MAS reduced AHI by 50.3% ± 50.7% across the group. Supinepredominant OSA patients had lower treatment response rates than non-positional OSA (e.g., 36% vs. 59% for AHI < 10/h). REM-predominant OSA showed a lower response rate than either NREM or non-stage dependent OSA. In prediction modelling, age, baseline AHI, and anthropometric variables were predictive of MAS treatment outcome but not OSA phenotype. Gender was not associated with treatment outcome. Conclusions: Lower MAS treatment response rates were observed in supine and REM sleep. In a large sample, we confi rm that demographic, anthropometric, and polysomnographic data only weakly inform about MAS effi cacy, supporting the need for alternative objective prediction methods to reliably select patients for MAS treatment.
AB - Study Objectives: Mandibular advancement splints (MAS) are an effective treatment for obstructive sleep apnea (OSA); however, therapeutic response is variable. Younger age, female gender, less obesity, and milder and supine-dependent OSA have variably been associated with treatment success in relatively small samples. Our objective was to utilize a large cohort of MAS treated patients (1) to compare effi cacy across patients with different phenotypes of OSA and (2) to assess demographic, anthropometric, and polysomnography variables as treatment response predictors. Methods: Retrospective analysis of MAS-treated patients participating in clinical trials in sleep centers in Sydney, Australia between years 2000-2013. All studies used equivalent customized two-piece MAS devices and treatment protocols. Treatment response was defi ned as (1) apneahypopnea index (AHI) < 5/h, (2) AHI < 10/h and ≥50% reduction, and (3) ≥ 50% AHI reduction. Results: A total of 425 patients (109 female) were included (age 51.2 ± 10.9 years, BMI 29.2 ± 5.0 kg/m2). MAS reduced AHI by 50.3% ± 50.7% across the group. Supinepredominant OSA patients had lower treatment response rates than non-positional OSA (e.g., 36% vs. 59% for AHI < 10/h). REM-predominant OSA showed a lower response rate than either NREM or non-stage dependent OSA. In prediction modelling, age, baseline AHI, and anthropometric variables were predictive of MAS treatment outcome but not OSA phenotype. Gender was not associated with treatment outcome. Conclusions: Lower MAS treatment response rates were observed in supine and REM sleep. In a large sample, we confi rm that demographic, anthropometric, and polysomnographic data only weakly inform about MAS effi cacy, supporting the need for alternative objective prediction methods to reliably select patients for MAS treatment.
KW - Obstructive sleep apnea
KW - Oral appliance
KW - Polysomnography
KW - Treatment response
UR - http://www.scopus.com/inward/record.url?scp=84931096833&partnerID=8YFLogxK
U2 - 10.5664/jcsm.4934
DO - 10.5664/jcsm.4934
M3 - Article
C2 - 25845897
AN - SCOPUS:84931096833
SN - 1550-9389
VL - 11
SP - 861
EP - 868
JO - Journal of Clinical Sleep Medicine
JF - Journal of Clinical Sleep Medicine
IS - 8
ER -